cbdMD Reports Fiscal 2025 Net Sales of Up to $19.3 Million and Reduced Net Loss

Reuters

2025/11/21

cbdMD Reports Fiscal 2025 Net Sales of Up to $19.3 Million and Reduced Net Loss

cbdMD Inc. reported preliminary unaudited financial results for the fourth quarter and full fiscal year ended September 30, 2025. Net sales revenue for fiscal 2025 is expected to range between $19.1 million and $19.3 million, compared to $19.5 million in fiscal 2024. For the fourth quarter of fiscal 2025, net sales revenue is expected to be between $4.7 million and $4.9 million, up from $4.6 million in the same period last year, representing an increase of 3% to 5%. The company expects its net loss for fiscal 2025 to improve to a range of $1.9 million to $2.1 million, compared to a net loss of $3.7 million in fiscal 2024. cbdMD highlighted actions taken to strengthen its business and operating model and reported positive sequential and year-over-year revenue growth for the fourth quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL30521) on November 21, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2585145612"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2585145612\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2585145612?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-21 21:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2585145612","market":"fut","top_or_hot":-1,"title":"cbdMD Reports Fiscal 2025 Net Sales of Up to $19.3 Million and Reduced Net Loss","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      cbdMD Reports Fiscal 2025 Net Sales of Up to $19.3 Million and Reduced Net Loss\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        cbdMD Inc. reported preliminary unaudited financial results for the fourth quarter and full fiscal year ended September 30, 2025. Net sales revenue for fiscal 2025 is expected to range between $19.1 million and $19.3 million, compared to $19.5 million in fiscal 2024. For the fourth quarter of fiscal 2025, net sales revenue is expected to be between $4.7 million and $4.9 million, up from $4.6 million in the same period last year, representing an increase of 3% to 5%. The company expects its net loss for fiscal 2025 to improve to a range of $1.9 million to $2.1 million, compared to a net loss of $3.7 million in fiscal 2024. cbdMD highlighted actions taken to strengthen its business and operating model and reported positive sequential and year-over-year revenue growth for the fourth quarter.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL30521) on November 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>cbdMD Reports Fiscal 2025 Net Sales of Up to $19.3 Million and Reduced Net Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\ncbdMD Reports Fiscal 2025 Net Sales of Up to $19.3 Million and Reduced Net Loss\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-11-21 21:30</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      cbdMD Reports Fiscal 2025 Net Sales of Up to $19.3 Million and Reduced Net Loss\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        cbdMD Inc. reported preliminary unaudited financial results for the fourth quarter and full fiscal year ended September 30, 2025. Net sales revenue for fiscal 2025 is expected to range between $19.1 million and $19.3 million, compared to $19.5 million in fiscal 2024. For the fourth quarter of fiscal 2025, net sales revenue is expected to be between $4.7 million and $4.9 million, up from $4.6 million in the same period last year, representing an increase of 3% to 5%. The company expects its net loss for fiscal 2025 to improve to a range of $1.9 million to $2.1 million, compared to a net loss of $3.7 million in fiscal 2024. cbdMD highlighted actions taken to strengthen its business and operating model and reported positive sequential and year-over-year revenue growth for the fourth quarter.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL30521) on November 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"YCBD","symbol_name":"cbdMD, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDLxjHQr:1","article_id":"2585145612","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2585145612","pubTimestamp":1763731816,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"cbdMD Inc. reported preliminary unaudited financial results for the fourth quarter and full fiscal year ended September 30, 2025. Net sales revenue for fiscal 2025 is expected to range between $19.1 million and $19.3 million, compared to $19.5 million in fiscal 2024. For the fourth quarter of fiscal 2025, net sales revenue is expected to be between $4.7 million and $4.9 million, up from $4.6 million in the same period last year, representing an increase of 3% to 5%. The company expects its net loss for fiscal 2025 to improve to a range of $1.9 million to $2.1 million, compared to a net loss of $3.7 million in fiscal 2024. cbdMD highlighted actions taken to strengthen its business and operating model and reported positive sequential and year-over-year revenue growth for the fourth quarter.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"YCBD":"cbdMD, Inc.","BK4007":"制药"},"translate_title":"cbdMD报告2025财年净销售额高达1930万美元，净亏损减少","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"YCBD":0.9},"content_text":"cbdMD Reports Fiscal 2025 Net Sales of Up to $19.3 Million and Reduced Net Loss\n    \n\n        cbdMD Inc. reported preliminary unaudited financial results for the fourth quarter and full fiscal year ended September 30, 2025. Net sales revenue for fiscal 2025 is expected to range between $19.1 million and $19.3 million, compared to $19.5 million in fiscal 2024. For the fourth quarter of fiscal 2025, net sales revenue is expected to be between $4.7 million and $4.9 million, up from $4.6 million in the same period last year, representing an increase of 3% to 5%. The company expects its net loss for fiscal 2025 to improve to a range of $1.9 million to $2.1 million, compared to a net loss of $3.7 million in fiscal 2024. cbdMD highlighted actions taken to strengthen its business and operating model and reported positive sequential and year-over-year revenue growth for the fourth quarter.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL30521) on November 21, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}